Let's have permanently quicker drug approvals

16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we ...

Read more →

A life-saving new drug for COVID-19 is found

16 June 2021 - But only rich countries will benefit, and even they will struggle to get hold of it. ...

Read more →

Expanded PBS listing to save Australians around $120,000 a year

17 June 2021 - More than 800 Australians with stage IV advanced or metastatic kidney cancer will now have improved access ...

Read more →

Medicare must study unproven, expensive Alzheimer’s drug

15 June 2021 - Tax payers and patients cannot afford to pay a high price for a treatment not known to ...

Read more →

Unaffordable treatment for severe malaria highlights U.S. drug market pitfalls

11 June 2021 - When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the only ...

Read more →

PHARMAC’s decision over diabetes drugs could see up to 140,000 ‘miss out’, doctor says

11 June 2021 - Dr John Baker​, the chair of the Diabetes Foundation Aotearoa, says that has to change and highlights ...

Read more →

Stop blaming PHARMAC - we'd be worse off without it

10 June 2021 - Penny Tucker is concerned that there are “miracle drugs and biologics that have transformed many conditions ...

Read more →

Alzheimer’s drug is bonanza for Biogen, most likely at taxpayer expense

8 June 2021 - The FDA’s decision on Monday to approve a new Alzheimer’s medication over the fierce objections of ...

Read more →

Amicus Therapeutics announces United Kingdom’s MHRA grants early access to AT-GAA

8 June 2021 - Permits All Eligible Individuals with Late-Onset Pompe Disease Access to AT-GAA Prior to Marketing Authorization in the ...

Read more →

Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access Aduhelm

7 June 2021 - Value based agreements in progress with Cigna and other payers. ...

Read more →

Robertson says PHARMAC's bulk buying model is 'different', not 'worse' than other OECD countries

8 June 2021 - The Deputy Prime Minister says the agency’s bulk buying model works for many Kiwis. ...

Read more →

Limiting coverage based on efficacy and safety: a path forward for Medicare regarding the Alzheimer’s treatment aducanumab

 7 June 2021 - Today, the FDA will announce a decision on whether to approve the biologic aducanumab, intended to alleviate ...

Read more →

Safer and more effective shingles vaccine will be available to Aussies - but it won’t come cheap

8 June 2021 - A new shingles vaccine almost twice as effective as the one currently available to Australians will ...

Read more →

Newly approved obesity drug Wegovy holds promise, but faces reimbursement challenges

5 June 2021 - On 4 June, the FDA approved Novo Nordisk’s obesity drug Wegovy (semaglutide), a glucagon-like peptide 1 receptor ...

Read more →

Most Americans support Medicare negotiation despite claims it would hurt innovation

3 June 2021 - A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support ...

Read more →